Elmar Kraus
Stock Analyst at DZ BANK AG
(4.21)
# 1,476
Out of 5,099 analysts
138
Total ratings
72.7%
Success rate
10.9%
Average return
Main Sectors:
Stocks Rated by Elmar Kraus
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| LON: AZN AstraZeneca PLC | Reiterated: Buy | n/a | $13,760.00 | - | 15 | Nov 3, 2026 | |
| MRK Merck & Co. | Downgraded: Hold | $148 → $153 | $144.67 | +5.76% | 3 | Nov 3, 2026 | |
| LON: GSK GSK plc | Reiterated: Hold | n/a | $1,827.50 | - | 11 | Oct 30, 2026 | |
| PFE Pfizer | Reiterated: Buy | n/a | $30.00 | - | 10 | Aug 6, 2026 | |
| EPA: SAN Sanofi | Reiterated: Buy | n/a | $80.98 | - | 10 | Jul 31, 2026 | |
| SWX: NOVN Novartis AG | Reiterated: Hold | n/a | $131.50 | - | 9 | Jul 22, 2026 | |
| SWX: ROP Roche Holding AG | Reiterated: Buy | n/a | $391.00 | - | 12 | Feb 2, 2026 | |
| ABBV AbbVie | Downgraded: Hold | $188 → $237 | $286.00 | n/a | 4 | Nov 4, 2025 | |
| AMS: PHIA Koninklijke Philips N.V. | Reiterated: Hold | n/a | $25.70 | n/a | 7 | Jul 29, 2025 | |
| GILD Gilead Sciences | Upgraded: Buy | $72 → $108 | $167.47 | n/a | 7 | Feb 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $331 → $343 | $461.26 | n/a | 5 | May 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $1,068 → $1,065 | $973.36 | n/a | 3 | May 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $820 → $800 | $1,409.38 | n/a | 6 | May 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $61 → $50 | $61.71 | n/a | 3 | Apr 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $181 → $176 | $266.17 | n/a | 2 | Apr 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $242 → $236 | $248.93 | n/a | 4 | Feb 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $39 | $23.13 | n/a | 1 | Nov 2, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $43.35 | n/a | 20 | Apr 20, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $48.70 | n/a | 1 | Feb 11, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $43.38 | n/a | 1 | Aug 24, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $90 → $92 | $98.88 | n/a | 2 | May 14, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $41 | $28.46 | n/a | 1 | Mar 24, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | n/a | $40.19 | n/a | 1 | May 3, 2018 |
AstraZeneca PLC
Nov 3, 2026
Reiterated: Buy
Price Target: n/a
Current: $13,760.00
Upside: -
Merck & Co.
Nov 3, 2026
Downgraded: Hold
Price Target: $148 → $153
Current: $144.67
Upside: +5.76%
GSK plc
Oct 30, 2026
Reiterated: Hold
Price Target: n/a
Current: $1,827.50
Upside: -
Pfizer
Aug 6, 2026
Reiterated: Buy
Price Target: n/a
Current: $30.00
Upside: -
Sanofi
Jul 31, 2026
Reiterated: Buy
Price Target: n/a
Current: $80.98
Upside: -
Novartis AG
Jul 22, 2026
Reiterated: Hold
Price Target: n/a
Current: $131.50
Upside: -
Roche Holding AG
Feb 2, 2026
Reiterated: Buy
Price Target: n/a
Current: $391.00
Upside: -
AbbVie
Nov 4, 2025
Downgraded: Hold
Price Target: $188 → $237
Current: $286.00
Upside: n/a
Koninklijke Philips N.V.
Jul 29, 2025
Reiterated: Hold
Price Target: n/a
Current: $25.70
Upside: n/a
Gilead Sciences
Feb 13, 2025
Upgraded: Buy
Price Target: $72 → $108
Current: $167.47
Upside: n/a
May 7, 2024
Reiterated: Buy
Price Target: $331 → $343
Current: $461.26
Upside: n/a
May 6, 2024
Reiterated: Buy
Price Target: $1,068 → $1,065
Current: $973.36
Upside: n/a
May 3, 2024
Reiterated: Hold
Price Target: $820 → $800
Current: $1,409.38
Upside: n/a
Apr 30, 2024
Reiterated: Buy
Price Target: $61 → $50
Current: $61.71
Upside: n/a
Apr 18, 2024
Reiterated: Buy
Price Target: $181 → $176
Current: $266.17
Upside: n/a
Feb 15, 2024
Reiterated: Hold
Price Target: $242 → $236
Current: $248.93
Upside: n/a
Nov 2, 2023
Reiterated: Buy
Price Target: $39
Current: $23.13
Upside: n/a
Apr 20, 2022
Reiterated: Hold
Price Target: n/a
Current: $43.35
Upside: n/a
Feb 11, 2022
Downgraded: Hold
Price Target: n/a
Current: $48.70
Upside: n/a
Aug 24, 2021
Reiterated: Buy
Price Target: n/a
Current: $43.38
Upside: n/a
May 14, 2020
Downgraded: Hold
Price Target: $90 → $92
Current: $98.88
Upside: n/a
Mar 24, 2020
Upgraded: Buy
Price Target: $41
Current: $28.46
Upside: n/a
May 3, 2018
Reiterated: Sell
Price Target: n/a
Current: $40.19
Upside: n/a